picropodophyllin has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| All-Ericsson, C; Axelson, M; Economou, MA; Girnita, L; Kvanta, A; Larsson, O; Menu, E; Rosengren, L; Seregard, S; van der Ploeg, I; Vasilcanu, D; Wu, J | 2 |
2 other study(ies) available for picropodophyllin and Choroid Neovascularization
| Article | Year |
|---|---|
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Topics: Administration, Oral; Animals; Blotting, Western; Cell Culture Techniques; Choroid; Choroidal Neovascularization; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Injections, Intraperitoneal; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; Pigment Epithelium of Eye; Podophyllotoxin; Receptor, IGF Type 1; Transfection; Vascular Endothelial Growth Factor A | 2008 |
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Line; Choroid; Choroidal Neovascularization; Enzyme-Linked Immunosorbent Assay; Humans; Injections, Intraperitoneal; Insulin-Like Growth Factor I; Lasers; Male; Mice; Mice, Inbred C57BL; Podophyllotoxin; Receptor, IGF Type 1; Retinal Pigment Epithelium; Vascular Endothelial Growth Factor A | 2008 |